Radiant Parenterals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.85 Cr
as on 18-07-2024
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.95 Cr
as on 18-07-2024
- Satisfied Charges ₹ 14.98 Cr
as on 18-07-2024
- Revenue -10.18%
(FY 2023)
- Profit -10.20%
(FY 2023)
- Ebitda -1.28%
(FY 2023)
- Net Worth 170.97%
(FY 2023)
- Total Assets -7.57%
(FY 2023)
About Radiant Parenterals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 1.85 Cr.
The company currently has active open charges totaling ₹12.95 Cr. The company has closed loans amounting to ₹14.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Radiant Parenterals Limited India is Surbhit Shah as CEO. Mukesh Shah, Amit Shah, Surbhit Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ1989PLC011784
- Company No.
011784
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Jan 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Baroda, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Radiant Parenterals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surbhit Shah | CEO | 19-Feb-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Shah  | Director | 20-Sep-1997 | Current |
| Amit Shah | Director | 01-Aug-2003 | Current |
| Ami Shah | Additional Director | 02-Apr-2024 | Current |
| Krima Shah | Additional Director | 02-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Radiant Parenterals.
Radiant Parenterals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.18% decrease. The company also saw a substantial fall in profitability, with a 10.2% decrease in profit. The company's net worth Soared by an impressive increase of 170.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radiant Parenterals?
In 2023, Radiant Parenterals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Rekvina Pharmaceuticals (India) Private LimitedActive 17 years 7 monthsMukesh Shah and Surbhit Shah are mutual person
Varshaben Mukeshbhai Shah FoundationActive 7 years 11 monthsMukesh Shah, Amit Shah and 1 more are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Jan 2023 | ₹2.60 Cr | Open |
Others Creation Date: 13 Jan 2023 | ₹2.60 Cr | Open |
Others Creation Date: 21 Oct 2021 | ₹2.06 M | Open |
How Many Employees Work at Radiant Parenterals?
Radiant Parenterals has a workforce of 42 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radiant Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radiant Parenterals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
